There are 398 resources available
Neo/adjuvant PARP inhibitors
Presenter: Andrew Tutt
Session: Genetic testing and implications in early breast cancer (eBC) patients
Resources:
Slides
Webcast
Who and how to test for BRCA mutations
Presenter: Christian Singer
Session: Genetic testing and implications in early breast cancer (eBC) patients
Resources:
Slides
Webcast
People with disabilities
Presenter: Marta Martinho
Session: EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence?
Resources:
Slides
Webcast
Surgical options for BRCA mutated eBC patients
Presenter: Maria Joao Cardoso
Session: Genetic testing and implications in early breast cancer (eBC) patients
Resources:
Slides
Webcast
Homeless people
Presenter: Carlos Fernandes Cargaleiro
Session: EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence?
Resources:
Slides
Webcast
Best additional systemic treatment options for eBC in the era of PARP inhibitors
Presenter: Sabine Linn
Session: Genetic testing and implications in early breast cancer (eBC) patients
Resources:
Slides
Webcast
Immigrants and refugees
Presenter: Stefano Terzoni
Session: EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence?
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Genetic testing and implications in early breast cancer (eBC) patients
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: EONS - Taking care of disadvantaged people with breast cancer: What’s the evidence?
Resources:
Webcast
LBA4 - Updated overall survival (OS) results from the first-line (1L) population in the Phase III MONALEESA-3 trial of postmenopausal patients (pts) with HR+/HER2? advanced breast cancer (ABC) treated with ribociclib (RIB) + fulvestrant (FUL)
Presenter: Patrick Neven
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast